APA (7th ed.) Citation

Habek, M., Drulovic, J., Brecl Jakob, G., Barbov, I., Radulovic, L., Rajda, C., . . . Turčáni, P. (2023). Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers. Neurology & Therapy, 12(1), 25. https://doi.org/10.1007/s40120-022-00422-z

Chicago Style (17th ed.) Citation

Habek, Mario, Jelena Drulovic, Gregor Brecl Jakob, Ivan Barbov, Ljiljana Radulovic, Cecilia Rajda, Konrad Rejdak, and Peter Turčáni. "Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers." Neurology & Therapy 12, no. 1 (2023): 25. https://doi.org/10.1007/s40120-022-00422-z.

MLA (9th ed.) Citation

Habek, Mario, et al. "Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers." Neurology & Therapy, vol. 12, no. 1, 2023, p. 25, https://doi.org/10.1007/s40120-022-00422-z.